Screening and detection of carbapenemases

Size: px
Start display at page:

Download "Screening and detection of carbapenemases"

Transcription

1 Screening and detection of carbapenemases For many isolates with carbapenemases the MICs of carbapenems are around the susceptible breakpoint making resistance difficult to detect - particularly with automated systems. Therefore special zone breakpoints are needed in first line screening Strains with reduced susceptibility to Imipenem, Meropenem (both inhibition zone < 22 mm) or Ertapenem (zone < 21mm) on Mueller-Hinton Agar with McFarland 0.5 inoculum, should be suspected of possessing carbapenemases. Most isolates with KPC and GES enzymes are highly resistant to Ceftazidime. Ertapenem Neo-Sensitabs is the most sensitive indicator for possible carbapenemase, but in approximately 20 % of cases other resistance mechanisms are involved (confirmation of carbapenemase with Modified Hodge Test is necessary). It is important to recognize small resistant colonies growing inside the Ertapenem disk zone.

2 A) PROCEDURE FOR METALLO BETA LACTAMASE (MBL) DETECTION. ENTEROBACTERIACEAE Apply one Dipicolinic Acid Diatabs (DPA) on an inoculated Mueller Hinton (MH) plate. Apply one Meropenem Neo-Sensitabs and one Ertapenem Neo-Sensitabs onto the plate on either side of the DPA, 5mm from the DPA (edge to edge). Apply Imipenem + EDTA (IM+ED) on an inoculated MH plate. Apply one Meropenem Neo-Sensitabs and one Ertapenem Neo-Sensitabs at either side of the Imipenem + EDTA, 10 mm from the Imipenem + EDTA (edge to edge). NON FERMENTERS Apply one DPA Diatabs on the MH plate. Apply one Imipenem Neo-Sensitabs and one Meropenem Neo-Sensitabs at either side of the DPA, 5 mm from the DPA (edge to edge). Apply Imipenem + EDTA (IM+ED) on the inoculated MH plate. Apply one Meropenem Neo Sensitabs and one Ertapenem Neo-Sensitabs at either side of the Imipenem + EDTA, 10 mm from the Imipenem + EDTA (edge to edge). INTERPRETATION The use of two chelating agents EDTA and DPA will enhance the detection of metallo ß lactamases (MBL) in the clinical laboratory. A key hole or ghost zone between carbapenems (one or more) and Dipicolinic Acid indicates the presence of an MBL. A key hole or ghost zone between IM+ED and the carbapenems (one or more) indicates the prescence of an MBL. A key hole or ghost zone between carbapenems (one or more) and Dipicolinic Acid indicates the presence of a MBL. Please note: Most MH agar brands contain physiological levels of Zn ++ ions and should be used for carbapenem testing. Iso Sensitest agar has low levels of zinc ions and may give false susceptibility results for carbapenems in the presence of MBL. Some MH agar brands should also be supplemented with zinc ions (70 mg zinc sulphate. H 2 O per liter medium). This applies also to the Modified Hodge Test (MHT). Strains of Acinetobacter baumannii producing certain oxacillinases may give a false positive metallo-ß-lactamase test result. Screening and detection of carbapenemases version C Page 2

3 B) PROCEDURE FOR KPC CARBAPENEMASES DETECTION (CLASS A ENZYMES) Isolates giving negative metallo beta lactamase tests, may produce other carbapenemases. The most current are KPC enzymes isolated from Enterobacteriaceae (K. pneumoniae, E. coli, Enterobacter spp., P. mirabilis) particularly K. pneumoniae. To detect these strains in rectal swab screening samples, direct plating on McConkey agar in the presence of Ertapenem Neo Sensitabs and Imipenem Neo Sensitabs may be used. Place one Amoxycillin + Clavulanate Neo Sensitabs between one Ertapenem and one Imipenem Neo Sensitabs (distance 10 mm from edge to edge). Place one Boronic Acid Diatabs between one Ertapenem and one Imipenem Neo Sensitabs (distance mm from edge to edge). Perform Modified Hodge Test (MHT) with Ertapenem and Meropenem Neo Sensitabs. INTERPRETATION The following results will presumably indicate the presence of a KPC beta lactamase: a) Negative metallo beta lactamases tests. b) Positive synergy test between Boronic Acid and the carbapenems (one or both). c) Negative synergy test between Cloxacillin 500 μg and the carbapenems (11). d) Positive synergy test between clavulanate (AMC) and carbapenems (one or both). Not always easy to see. Although isolates with ESBL + impermeability will give false positive results. e) Positive Modified Hodge Test. Please notice: Test only ertapenem resistant strains. Ertapenem susceptible strains may provide a false positive result with Boronic Acid. Conclusion: Reduced susceptibility to ertapenem, synergy between Boronic Acid and the carbapenems, and no synergy between Cloxacillin 500 g and the carbapenems is clearly indicative of KPC enzyme being present. Isolates producing high level AmpC + impermeability can be detected by synergy between Cloxacillin 500 μg and the carbapenems (11). Screening and detection of carbapenemases version C Page 3

4 C) PROCEDURE FOR OXACILLINASE DETECTION (CLASS D ENZYMES) Strains producing oxacillinases will currently show zones of inhibition < 21 mm with Ertapenem and/or <23 mm with Meropenem Neo Sensitabs. Most are resistant to Aztreonam. These enzymes are mainly found in Acinetobacter baumannii but also in Enterobacteriaceae (K. pneumoniae, Enterobacter) and P. aeruginosa although these are rare. INTERPRETATION The following results will presumably indicate the presence of oxacillinases: a) Negative metallo beta lactamase tests. b) Negative (or weak positive) synergy test between clavulanate (AMC) and carbapenems (one or both). c) Positive Modified Hodge Test. (Addition of zinc ions: 70 mg zinc sulphate.h20 /liter medium may be necessary to detect oxacillinases). An isolate is counted positive when it fulfils the 3 criteria MER IM+ED ERT BOR BOR AMC DPA MER ERT CLOX CLOX 10 AMC Screening of carbapenemases IM+ED = Imipenem + EDTA Neo S, MER = Meropenem Neo S, ERT = Ertapenem Neo S, DPA = Dipicolinic Acid Diatabs, AMC = Amoxycillin+Clavulanate Neo S. CLOX = Cloxacillin 500 μg Diatabs With non fermenters use Imipenem Neo S instead of Ertapenem Neo S. Screening and detection of carbapenemases version C Page 4

5 MODIFIED HODGE TEST (MHT) Is used to determine if resistance to carbapenems is caused by a carbapenemase. A MH agar plate (or a McConkey plate) is inoculated with the susceptible strain E. coli ATCC (Mc Farland 0.5, diluted 1/10) as for disk diffusion. When testing Enterobacteriaceae, one Ertapenem Neo Sensitabs and one Meropenem Neo Sensitabs are applied onto the plate approx. 30 mm apart from each other. For non fermenters one Imipenem Neo Sensitabs and one Meropenem Neo Sensitabs are applied. A suspension of the microorganism to be tested for carbapenemase is adjusted to Mc Farland 0.5 standard and a loop is used to make a streak passing through the two carbapenem disks. Two more streaks are placed perpendicularly making a cross. Thereafter incubation for hours at C. Alteration in the shape (indentation) of the zones of inhibition around the test organism is considered indicitive of the presence of a carbapenemase (figure). Ertapenem Meropenem K. pneumoniae KPC positive Modified Hodge Test (MHT) With non fermenters use Imipenem Neo S instead of Ertapenem. Screening and detection of carbapenemases version C Page 5

6 PRODUCTS MENTIONED IN THE BROCHURE INCLUDING REF NO: DIATABS Product code Diatabs Boronic Acid Dipicolinic Acid Cloxacillin 500 μg NEO SENSITABS Product code Original Neo Sensitabs Product code CLSI potency Neo Sensitabs Ertapenem 10 µg Ertapenem 10 µg 80512N Imipenem+EDTA 80512N Imipenem+EDTA Meropenem 10 µg 4312 Meropenem 10 µg 7412 Imipenem 15 µg 1212 Imipenem 10 µg Amoxycillin + Clavulanate ( µg) 0112 Amoxycillin + Clavulanate ( µg) REFERENCES 1) Smith Moland E et al : Newer beta lactamases : Clinical and Laboratory implications.clin Microbiol Newsletter 30, 71 84,2008 2) Kyeong Seob Shin et al : Dipicolinic acid based disk methods for detection of metallo beta lactamase producing Pseudomonas spp and Acinetobacter spp. Diagn Microbiol Infect Dis,2, , ) Soichiro Kimura et al : Evaluation of dipicolinic acid for detection of IMP or VIM type metallo beta lactamase producing P aeruginosa clinical isolates. Diagn Microbiol Infect Dis 53, ,2005 4) Pasteran FG et al : Klebsiella pneumoniae Carbapenemase 2,Buenos Aires,Argentina. Emerg Infect Dis 14, , ) Bradford PA et al: Emergence of carbapenem resistant Klebsiella spp possessing the class A carbapenem hydrolyzing KPC 2 and inhibitor resistant TEM 30 beta lactamases in New York City. Clin Infect Dis 39,55 0,2004. ) Poirel L et al : Carbapenem resistance in A. baumannii : mechanisms and epidemiology. Clin Microbiol Infect 12,82 83,200. 7) Yilmaz M et al : Warning! Oxacillinase mediated carbapenem resistance spreading in Enterobacteriaceae. Presentation P 1517, ECCMID 2008,Barcelona. 8) Cuzon G et al : Plasmid encoded carbapenem hydrolyzing beta lactamase OXA 48 in an Imipenem susceptible K. pneumoniae strain from Belgium. Antimicr Ag. Chemother. 52, , ) Tsakris A. et al: First occurence of KPC-possessing K. Pneumoniae in a Greek hospital and recommendation for detection with Boronic Acid disc tests. J.A.C. 2, , ) Doi Y. et al: Simple disk-based method for detection of K. pneumonia carbapenemase-type beta lactamase by use of a Boronic Acid compound. J.C.M. 4, , ) Giske Chr. : Personal communication, 2009 Page

Insert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J

Insert for Kit 98006/98010/ KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J Insert for Kit 98006/98010/98015 KPC/Metallo-B-Lactamase Confirm Kit KPC+MBL detection Kit KPC/MBL and OXA-48 Confirm Kit REVISION: DBV0034J DATE OF ISSUE: 09.02.2017 LANGUAGE: English FOR IN VITRO DIAGNOSTIC

More information

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase

Sensitive and specific Modified Hodge Test for KPC and metallo-beta-lactamase JCM Accepts, published online ahead of print on 19 October 2011 J. Clin. Microbiol. doi:10.1128/jcm.05602-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Detecting carbapenemases in Enterobacteriaceae

Detecting carbapenemases in Enterobacteriaceae Detecting carbapenemases in Enterobacteriaceae David Livermore Health Protection Agency, Colindale, London 12 August 2003 Mechanisms of carbapenem R in Enterobacteria Impermeability + AmpC or ESBL Metallo

More information

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide

More information

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011

Received 31 January 2011/Returned for modification 2 March 2011/Accepted 15 March 2011 JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1965 1969 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.00203-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Comparative

More information

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial

More information

Detecting CRE. what does one need to do?

Detecting CRE. what does one need to do? 5 th ICAN Conference, Harare 4 th November 2014 Room 2: 10:30-12:00 Detecting CRE (Carbapenem-resistant Enterobacteriaceae) what does one need to do? Dr Nizam Damani Associate Medical Director Infection

More information

Phenotypic detection of ESBLs and carbapenemases

Phenotypic detection of ESBLs and carbapenemases Phenotypic detection of ESBLs and carbapenemases Standardized susceptibility testing residential workshop 2016 Katie Hopkins PhD Clinical Scientist Antimicrobial Resistance and Healthcare Associated Infections

More information

Detection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates

Detection of Carbapenem Resistant Enterobacteriacae from Clinical Isolates International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 5 (2016) pp. 864-869 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.505.089

More information

Original Article Clinical Microbiology

Original Article Clinical Microbiology Original Article Clinical Microbiology Ann Lab Med 2015;35:212-219 http://dx.doi.org/10.3343/alm.2015.35.2.212 ISSN 2234-3806 eissn 2234-3814 Combined Use of the Modified Hodge Test and Carbapenemase Inhibition

More information

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria

In-House Standardization of Carba NP Test for Carbapenemase Detection in Gram Negative Bacteria International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.342

More information

Educational Workshops 2016

Educational Workshops 2016 Educational Workshops 2016 Keynote CPE Screening We are grateful to Dr Andrew Dodgson, Consultant Microbiologist, Public Health England and Central Manchester Hospitals NHS Foundation Trust Terminology

More information

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools. JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks

More information

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs. Detection of beta lactamases. Carbapenemases and phenotypic methods for detection

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs. Detection of beta lactamases. Carbapenemases and phenotypic methods for detection Carbapenemases and phenotypic methods for detection Carbapenemases are beta-lactamases that significantly hydrolyze at least imipenem and/or meropenem. Carbapenemases involved in acquired resistance are

More information

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions Dr. Andrew Walkty Medical Microbiologist, Diagnostic Services Manitoba (DSM) June. 17,

More information

Carbapenems and Enterobacteriaceae

Carbapenems and Enterobacteriaceae Title Carbapenems and Enterobacteriaceae Presenter s details NHLS Dr Khine Swe Swe/Han FC Path ( Micro), SA MMed( micro), SA DTMH(Wits univ),sa PDIC(Stellen univ)sa MB,BS(Yangon),Myanmar Pathologist,Consultant/Lecturer,

More information

Combined disk methods for the detection of KPC- and/or VIM-positive. Klebsiella pneumoniae: improving reliability for the double carbapenemase

Combined disk methods for the detection of KPC- and/or VIM-positive. Klebsiella pneumoniae: improving reliability for the double carbapenemase Received Date : 27-Dec-2012 Revised Date : 30-Mar-2013 Accepted Date : 31-Mar-2013 Article type : Research Note - online only Combined disk methods for the detection of KPC- and/or VIM-positive Klebsiella

More information

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms

Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms ORIGINAL ARTICLE Evaluation of CHROMagar msupercarba for the detection of carbapenemaseproducing Gram-negative organisms Julie Creighton and Hui Wang Canterbury Health Laboratories, Christchurch ABSTRACT

More information

Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae

Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae ISSN: 2319-7706 Volume 4 Number 6 (2015) pp. 547-552 http://www.ijcmas.com Original Research Article Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae Sathya Pandurangan 1,

More information

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School

Carbapenemases in Enterobacteriaceae: Prof P. Nordmann Bicêtre hospital, South-Paris Med School Carbapenemases in Enterobacteriaceae: 2012 Prof P. Nordmann Bicêtre hospital, South-Paris Med School March 21, 2012 Trends in Molecular Medecine NDM IMP OXA-48 KPC VIM ALERT VI M KPC KPC NDM I MP OXA-

More information

Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa

Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Methodological and interpretative problems in antimicrobial susceptiblity tests of P. aeruginosa Y. Glupczynski Laboratoire de bactériologie Cliniques Universitaires UCL de Mont-Godinne Université Catholique

More information

Carbapenemase-producing Enterobacteriaceae

Carbapenemase-producing Enterobacteriaceae Carbapenemase-producing Enterobacteriaceae 2012 CNR Associé Résistance aux Antibiotiques Prof. P. Nordmann Carbapenemases in Enterobacteriaceae May, 2012 Penicillins Cephalosporins Carbapenems Extended-spectrum

More information

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review

More information

Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method?

Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method? Detecting Carbapenemase-Producing Enterobacteriaceae: why isn t there a single best method? Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown

More information

Nature and Science 2017;15(10)

Nature and Science 2017;15(10) Evaluation of Substrate Profile Test for Detection of Metallobetalactamses among Imipenem Resistant Clinical Isolates of Gram Negative Bacteria Tarek El-said El-Banna, Fatma Ibrahim Sonboland Eslam Shaaban

More information

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch

ORIGINAL ARTICLE. Julie Creighton and Clare Tibbs. Canterbury Health Laboratories, Christchurch ORIGINAL ARTICLE Evaluation of the MAST indirect carbapenemase test and comparison with a modified carbapenem inactivation method for the detection of carbapenemase enzymes in Gram-negative bacteria Julie

More information

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Original article: Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Manish Bansal 1, Nitya Vyas 2, Babita Sharma 3, R.K.Maheshwari 4 1PG Resident, 2 Professor, 3 Assistant

More information

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore

#Corresponding author: Pathology Department, Singapore General Hospital, 20 College. Road, Academia, Level 7, Diagnostics Tower, , Singapore AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01754-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Title: Escherichia

More information

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE Veroniek Saegeman Veroniek Saegeman UZLeuven Carbapenemase producing Enterobacteriaceae (CPE) Introduction on antibiotic resistance Classification of ß-lactamases

More information

Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories

Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories REVIEW 10.1111/1469-0691.12678 Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories J. Hrabak, E. Chudackova and C. C. Papagiannitsis Department of

More information

Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System

Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System Supplementary Material Hofko M et al., Detection of carbapenemases by real-time PCR and melt-curve analysis on the BD MAX TM System Supplementary Material and Methods Characterization of isolates by the

More information

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs

Detection of resistance mechanisms using Neo- Sensitabs and Diatabs Page 1 / 42 - Document: 1.5.0 Carbapenemases Carbapenemases are beta-lactamases that significantly hydrolyze at least imipenem and/or meropenem. Carbapenemases involved in acquired resistance are of Ambler

More information

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms

Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases in Gram-Negative Bacteria With Characterized Resistance Mechanisms Original Article Clinical Microbiology Ann Lab Med 2017;37:305-312 https://doi.org/10.3343/alm.2017.37.4.305 ISSN 2234-3806 eissn 2234-3814 Evaluation of Six Phenotypic Methods for the Detection of Carbapenemases

More information

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection

New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection New Mechanisms of Antimicrobial Resistance and Methods for Carbapenemase Detection Stephen G. Jenkins, PhD, F(AAM), D(ABMM) Professor of Pathology and Laboratory Medicine Professor of Pathology in Medicine

More information

Rapid detection of carbapenemase-producing Pseudomonas spp.

Rapid detection of carbapenemase-producing Pseudomonas spp. JCM Accepts, published online ahead of print on 12 September 2012 J. Clin. Microbiol. doi:10.1128/jcm.01597-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Rapid detection

More information

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae

Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae James Cohen Stuart, Maurine A. Leverstein-Van Hall To cite this version: James Cohen Stuart, Maurine A. Leverstein-Van

More information

Detection of SPM-1-producing Pseudomonas aeruginosa and CHDL-producing. Acinetobacter baumannii using Liquid Chromatography Mass Spectrometry

Detection of SPM-1-producing Pseudomonas aeruginosa and CHDL-producing. Acinetobacter baumannii using Liquid Chromatography Mass Spectrometry JCM Accepts, published online ahead of print on 24 October 2012 J. Clin. Microbiol. doi:10.1128/jcm.02365-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. [Brief Report] Carvalhaes

More information

Use of Faropenem as an Indicator of Carbapenemase Activity

Use of Faropenem as an Indicator of Carbapenemase Activity JCM Accepts, published online ahead of print on 10 April 2013 J. Clin. Microbiol. doi:10.1128/jcm.00720-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Use of Faropenem as

More information

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18

More information

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

More information

(Plasmid mediated) Carbapenemases. Timothy R. Walsh, Cardiff University, Wales

(Plasmid mediated) Carbapenemases. Timothy R. Walsh, Cardiff University, Wales (Plasmid mediated) Carbapenemases Timothy R. Walsh, Cardiff University, Wales What is a carbapenemase? How much carbapenem do they need to breakdown before they are called a carbapenemase? ESBL-enzymes

More information

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa

More information

Update on CLSI and EUCAST

Update on CLSI and EUCAST Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»

More information

Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland

Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland Standardisation of testing for Carbapenemase Producing Organisms (CPO) in Scotland Version 1.0 7 June 2017 Revision Date June 2018 Scottish Microbiology and Virology Network (SMVN) SMVN Standardisation

More information

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the

More information

North Carolina CRE Laboratory Task Force

North Carolina CRE Laboratory Task Force North Carolina CRE Laboratory Task Force Carbapenem-Resistant Enterobacteriaceae (CRE) Screening and Confirmatory Testing Recommendations in North Carolina 2018 Consensus guidelines developed by the North

More information

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in

Revised AAC Version 2» New-Data Letter to the Editor ACCEPTED. Plasmid-Mediated Carbapenem-Hydrolyzing β-lactamase KPC-2 in AAC Accepts, published online ahead of print on 3 December 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01180-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Development of a phenotypic method for fecal carriage detection of OXA-48-producing

Development of a phenotypic method for fecal carriage detection of OXA-48-producing JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00055-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

2612 Page. *Yusuf, I 1., Rabiu A.T 1., Haruna, M 2. and Abdullahi, S. A 3. Phone:

2612 Page. *Yusuf, I 1., Rabiu A.T 1., Haruna, M 2. and Abdullahi, S. A 3. Phone: Carbapenem-Resistant Enterobacteriaceae (CRE) in Intensive Care Units and Surgical Wards of hospitals with no history of carbapenem usage in Kano, North West Nigeria *Yusuf, I 1., Rabiu A.T 1., Haruna,

More information

β CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE

β CARBA Test Rapid detection of carbapenemase-producing Enterobacteriaceae strains Contents 1. INTENDED USE β CARBA Test 25 68260 Rapid detection of carbapenemase-producing Enterobacteriaceae strains 881159 2015/05 Contents 1. INTENDED USE 2. SUMMARY AND EXPLANATION OF THE TEST 3. PRINCIPLE OF THE PROCEDURE

More information

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T

More information

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA

More information

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann

Rapid identification of emerging resistance in Gram negatives. Prof. Patrice Nordmann Rapid identification of emerging resistance in Gram negatives Prof. Patrice Nordmann Emerging Resistance threats, CDC USA-2013 Enterobacteriaceae producing extendedspectrum β-lactamases (ESBL) Multi-resistant

More information

Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients

Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients Indian J Med Res 127, April 2008, pp 398-402 Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients Ami Varaiya, Nikhil Kulkarni, Manasi Kulkarni, Pallavi Bhalekar & Jyotsana

More information

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL 3 rd joint meeting on AMR in Salmonella and Campylobacter, Copenhagen 7 April 2017 Antimicrobial

More information

Scottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service

Scottish Microbiology and Virology Network. Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service Scottish Microbiology and Virology Network Carbapenemase producers: screening and the new Scottish AMR Satellite Reference Laboratory Service Total number of carbapenemase producing organisms isolated

More information

β-lactamase inhibitors

β-lactamase inhibitors β-lactamase inhibitors Properties, microbiology & enzymology DAVID M LIVERMORE Professor of Medical Microbiology, UEA Lead on Antibiotic Resistance, Public Health England β-lactamase classes A B C D Serine

More information

ARTICLE IN PRESS International Journal of Antimicrobial Agents xxx (2010) xxx xxx

ARTICLE IN PRESS International Journal of Antimicrobial Agents xxx (2010) xxx xxx International Journal of Antimicrobial Agents xxx (2010) xxx xxx Contents lists available at ScienceDirect International Journal of Antimicrobial Agents journal homepage: http://www.elsevier.com/locate/ijantimicag

More information

Identification and screening of carbapenemase-producing Enterobacteriaceae

Identification and screening of carbapenemase-producing Enterobacteriaceae REVIEW 10.1111/j.1469-0691.2012.03815.x Identification and screening of carbapenemase-producing Enterobacteriaceae P. Nordmann 1, M. Gniadkowski 2, C. G. Giske 3, L. Poirel 1, N. Woodford 4, V. Miriagou

More information

Carbapenemases: A Review

Carbapenemases: A Review Review Article Carbapenemases: A Review Shalley Dahiya 1, Pooja Singla 2, Uma Chaudhary 3, Bijender Singh 4 1 Medical Offi cer, Department of Microbiology, BPS Government Medical College for Women, Khanpur

More information

K. Lee, Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong*

K. Lee, Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong* JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2003, p. 4623 4629 Vol. 41, No. 10 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.10.4623 4629.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

SUPPLEMENTAL TESTING. Tan Thean Yen

SUPPLEMENTAL TESTING. Tan Thean Yen SUPPLEMETAL TESTG Tan Thean Yen To Supplement Definition: add as a supplement to what seems insufficient "supplement your diet" Why supplement? urrent methods don t work well Additional information provided

More information

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic

More information

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn

Results and experience of BARN ESBL project. Marina Ivanova and project team Tallinn Results and experience of BARN ESBL project Marina Ivanova and project team Tallinn 13.05.2013 Aim of the project Improvement of detection and surveillance of resistance caused by extended spectrum betalactamase

More information

Laboratory testing for carbapenems resistant Enterobacteriacae (CRE)

Laboratory testing for carbapenems resistant Enterobacteriacae (CRE) Laboratory testing for carbapenems resistant Enterobacteriacae (CRE) Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Senior lecturer WITS, 9 th March 2013

More information

Journal of Infectious Diseases and

Journal of Infectious Diseases and Journal of Infectious Diseases & Therapy ISSN: 2332-0877 Journal of Infectious Diseases and Therapy Santanirand et al., J Infect Dis Ther 2018, 6:5 DOI: 10.4172/2332-0877.1000378 Research Article Open

More information

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac

AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi: /aac AAC Accepts, published online ahead of print on 13 October 2008 Antimicrob. Agents Chemother. doi:10.1128/aac.00931-08 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Abstract. Introduction. Editor: R. Canton

Abstract. Introduction. Editor: R. Canton ORIGINAL ARTICLE BACTERIOLOGY A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry,

More information

β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication

β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication Prevalence of Carbapenem-Hydrolyzing β- Lactamase Gene carrying Klebsiella pneumoniae and its Clinical Implication David Alcid M.D Balaji Yegneswaran M.D. Wanpen Numsuwan Introduction Klebsiella pneumoniae

More information

Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae

Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae Bartolini et al. Gut Pathogens 2014, 6:13 RESEARCH Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae Andrea Bartolini 1, Ilaria Frasson 2, Antonietta Cavallaro

More information

Toolkit for the Management of Carbapenemase Producing Organisms (CPO)

Toolkit for the Management of Carbapenemase Producing Organisms (CPO) Toolkit for the Management of Carbapenemase Producing Organisms (CPO) Prepared by: Provincial Infection Control Network of British Columbia (PICNet) September 2014 V1.1 Feb 2015 Provincial Infection Control

More information

Emergence of non-kpc carbapenemases: NDM and more

Emergence of non-kpc carbapenemases: NDM and more Emergence of non-kpc carbapenemases: NDM and more --- David Livermore Health Protection Agency, UK The first acquired carbapenemase to be recognised in gram-negative bacteria was IMP-1, a metallo-type,

More information

Controversial Issues in Susceptibility Testing: Point/Counterpoint. April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM)

Controversial Issues in Susceptibility Testing: Point/Counterpoint. April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM) Controversial Issues in Susceptibility Testing: Point/Counterpoint April N. Abbott, PhD D(ABMM) Romney M. Humphries, PhD D(ABMM) Disclosures RMH: Funding from BD, biomerieux, Beckman-Coulter, GenMark,

More information

False susceptibility of antibitoics to carbapenemase producers and means to overcome

False susceptibility of antibitoics to carbapenemase producers and means to overcome IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-3008, p-issn:2319-7676. Volume 9, Issue 2 Ver. II (Mar-Apr. 2014), PP 155-161 False susceptibility of antibitoics to carbapenemase

More information

SSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 4 April 2015

SSRG International Journal of Medical Science (SSRG-IJMS) volume 2 Issue 4 April 2015 Utilization of MacConkeyMeropenem screening Agar for the Detection of Carbapenem Resistanant Enterobacteriaceae in a tertiary care hospital Sanjeev Kumar 1, Anamika Vyas 2, S.K.Mehra 3 1,3 Department of

More information

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry

Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by MALDI- TOF mass spectrometry JCM Accepts, published online ahead of print on 2 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.01002-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12

More information

Activity of tigecycline alone and in combination with colistin and meropenem against carbapenemase

Activity of tigecycline alone and in combination with colistin and meropenem against carbapenemase Activity of tigecycline alone and in combination with colistin and meropenem against carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay Spyros Pournaras, Georgia Vrioni, Evangelia

More information

AST issues of polymyxins and their implications for the routine laboratory

AST issues of polymyxins and their implications for the routine laboratory AST issues of polymyxins and their implications for the routine laboratory Christian G. Giske, MD/PhD Chief consultant physician/associate professor Chairman of EUCAST Karolinska Institute and University

More information

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator EUCAST Frequently Asked Questions Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator Erika Matuschek EUCAST Development Laboratory, Växjö Sweden Monday 24

More information

Why some tests are no longer recommended

Why some tests are no longer recommended 8 th July 2014 Why some tests are no longer recommended Robin A Howe, Cardiff, UK Antimicrobial use in Primary Care Tests that are no longer recommended Burkholderia cepacia complex testing Stenotrophomonas

More information

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program

Disclosure. Objectives. Evolution of β Lactamases. Extended Spectrum β Lactamases: The New Normal. Prevalence of ESBL Mystic Program 47 th Annual Meeting August 2-4, 2013 Orlando, FL Extended Spectrum β Lactamases: The New Normal Disclosure I do have a vested interest in or affiliation with the following companies or organizations Triax

More information

Clinical Microbiology Newsletter

Clinical Microbiology Newsletter Clinical Microbiology Newsletter $88 Vol. 30, No. 10 www.cmnewsletter.com May 15, 2008 Newer β-lactamases: Clinical and Laboratory Implications, Part I * Ellen Smith Moland, B.S.M.T., Soo-Young Kim, M.D.,

More information

COMMENTARY. Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues. Kenneth S. Thomson*

COMMENTARY. Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues. Kenneth S. Thomson* JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2010, p. 1019 1025 Vol. 48, No. 4 0095-1137/10/$12.00 doi:10.1128/jcm.00219-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. COMMENTARY

More information

Multidrug-resistant organisms are a major public health

Multidrug-resistant organisms are a major public health Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae Nora Chea, Sandra N. Bulens, Thiphasone Kongphet-Tran, Ruth Lynfield, Kristin M.

More information

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals

Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals Recommendations for the Management of Carbapenem- Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals Minnesota Department of Health 11/2011 Infectious Disease Epidemiology,

More information

Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures

Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures ORIGINAL ARTICLE BACTERIOLOGY Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures L. Dortet 1,L.Brechard 1, L. Poirel 1,2 and P. Nordmann 1,2 1) Service de Bacteriologie-Virologie,

More information

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues REVIEW 10.1111/j.1469-0691.2009.03116.x Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues V. Miriagou 1, G. Cornaglia 2, M. Edelstein 3, I. Galani 4, C. G.

More information

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated AAC Accepted Manuscript Posted Online 21 November 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01820-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10

More information

Fernando Pasteran, Tania Mendez, Melina Rapoport, Leonor Guerriero, and Alejandra Corso*

Fernando Pasteran, Tania Mendez, Melina Rapoport, Leonor Guerriero, and Alejandra Corso* JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2010, p. 1323 1332 Vol. 48, No. 4 0095-1137/10/$12.00 doi:10.1128/jcm.01771-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Controlling

More information

Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India

Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India Mittal et al. BMC Microbiology (2016) 16:138 DOI 10.1186/s12866-016-0763-y RESEARCH ARTICLE Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients

More information

International Journal of Current Microbiology and Applied Sciences ISSN: Volume 7 Number 01 (2018) Journal homepage:

International Journal of Current Microbiology and Applied Sciences ISSN: Volume 7 Number 01 (2018) Journal homepage: International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.359

More information

Expert rules. for Gram-negatives

Expert rules. for Gram-negatives Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University

More information

Reporting blood culture results to clinicians: MIC, resistance mechanisms, both?

Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Reporting blood culture results to clinicians: MIC, resistance mechanisms, both? Christian G. Giske, MD, PhD Senior Consultant Physician/Associate Professor Department of Clinical Microbiology Karolinska

More information

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test

Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test Published in which should be cited to refer to this work. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test Carbapenem

More information

Enterobacteriaceae with acquired carbapenemases, 2016

Enterobacteriaceae with acquired carbapenemases, 2016 Enterobacteriaceae with acquired carbapenemases, 2016 Background The acquired or transferable (as opposed to chromosomally encoded) carbapenemases found in Enterobacteriaceae belong to three of the four

More information

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan

ST11 KPC-2 Klebsiella pneumoniae detected in Taiwan AAC Accepts, published online ahead of print on 30 January 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.05576-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5

More information

Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenemresistant Gram-negative bacilli in community settings

Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenemresistant Gram-negative bacilli in community settings Brief Original Article Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenemresistant Gram-negative bacilli in community settings Hugo Edgardo Villar, Marisa Noemí Baserni, Monica Beatriz

More information

suspected KPC and other carbapenemase producers among species of Nacional de Enfermedades Infecciosas (INEI)- ANLIS Dr. Carlos G.

suspected KPC and other carbapenemase producers among species of Nacional de Enfermedades Infecciosas (INEI)- ANLIS Dr. Carlos G. JCM Accepts, published online ahead of print on 1 December 0 J. Clin. Microbiol. doi:./jcm.0- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

Multicenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in

Multicenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in Multicenter study of the prevalence and the resistance mechanisms of carbapenem-resistant Enterobacteriaceae (CPE) in Belgium in 2011-2012 Study conducted by: 1. National Reference Center (NRC) for ESBL-producing

More information